Tesamorelin

$79

Tesamorelin is a synthetic GHRH analogue studied as a research tool for investigating growth hormone–releasing hormone receptor (GHRHR) signaling. Experimental systems evaluate its receptor-coupled intracellular pathways and downstream somatotropic axis dynamics. Laboratory investigations are confined to non-clinical research settings without therapeutic or medical claims.

  • $79 / month — Save 10%

Description

What It Is Tesamorelin is a stabilized synthetic analogue of growth hormone–releasing hormone (GHRH 1–44) studied in laboratory research as a ligand for the growth hormone–releasing hormone receptor (GHRHR).
What It’s Derived From Tesamorelin is derived from the endogenous 44–amino–acid GHRH sequence and incorporates a trans-3-hexenoic acid modification to enhance peptide stability and receptor-binding characteristics in experimental systems.
What Research Focuses On Research evaluates Tesamorelin in in vitro and preclinical models examining GHRHR activation, receptor-binding kinetics, downstream cAMP-mediated signaling pathways, somatotropic axis modulation, and GH/IGF-associated molecular readouts under controlled laboratory conditions.

Additional information

Weight 0.0125 lbs
Dimensions 0.625 × 0.625 × 1.5 in
Dosage

10mg

Reviews

There are no reviews yet.

Be the first to review “Tesamorelin”

Your email address will not be published. Required fields are marked *